ANAPC16 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.780800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.922800E-01
Normal-vs-Stage2
3.683800E-01
Normal-vs-Stage3
1.149040E-01
Normal-vs-Stage4
2.288200E-01
Stage1-vs-Stage2
3.757600E-01
Stage1-vs-Stage3
6.131900E-02
Stage1-vs-Stage4
3.591000E-01
Stage2-vs-Stage3
1.563410E-01
Stage2-vs-Stage4
7.849000E-01
Stage3-vs-Stage4
3.349200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.916600E-01
Normal-vs-AfricanAmerican
3.892200E-01
Normal-vs-Asian
2.542000E-01
Caucasian-vs-AfricanAmerican
9.446200E-01
Caucasian-vs-Asian
3.178800E-03
AfricanAmerican-vs-Asian
4.858500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.809800E-01
Normal-vs-Female
3.748600E-01
Male-vs-Female
8.750400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.874000E-01
Normal-vs-Age(41-60Yrs)
4.573600E-01
Normal-vs-Age(61-80Yrs)
3.425400E-01
Normal-vs-Age(81-100Yrs)
3.763800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.438600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.489200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.425400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.190100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.648000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.178200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.464000E-01
Normal-vs-Daily Drinker
3.880200E-01
Normal-vs-Weekly Drinker
2.721600E-01
Normal-vs-Occasional Drinker
3.066000E-01
Normal-vs-Social Drinker
3.238800E-01
Non Drinker-vs-Daily Drinker
5.639200E-01
Non Drinker-vs-Weekly Drinker
1.924230E-01
Non Drinker-vs-Occasional Drinker
1.452600E-01
Non Drinker-vs-Social Drinker
2.241800E-01
Daily Drinker-vs-Weekly Drinker
9.255800E-02
Daily Drinker-vs-Occasional Drinker
2.918000E-01
Daily Drinker-vs-Social Drinker
3.649800E-01
Weekly Drinker-vs-Occasional Drinker
2.080500E-02
Weekly Drinker-vs-Social Drinker
4.862200E-02
Occasional Drinker-vs-Social Drinker
9.472000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.547600E-02
Normal-vs-Grade 2
3.335400E-03
Normal-vs-Grade 3
5.359300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.067000E-01
Grade 1-vs-Grade 3
4.622600E-01
Grade 1-vs-Grade 4
3.547600E-02
Grade 2-vs-Grade 3
6.733000E-01
Grade 2-vs-Grade 4
3.335400E-03
Grade 3-vs-Grade 4
5.359300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.441600E-01
Normal-vs-NonDiabetic
3.850800E-01
Diabetic-vs-NonDiabetic
3.944800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.348000E-01
Normal-vs-NoPancreatitis
3.748200E-01
Pancreatitis-vs-NoPancreatitis
3.161600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.837700E-02
Normal-vs-N1
3.661400E-01
N0-vs-N1
3.699600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.345000E-01
Normal-vs-TP53-NonMutant
6.026400E-01
TP53-Mutant-vs-TP53-NonMutant
3.857800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
